Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Effects of acute or repeated paroxetine and fluoxetine treatment on affective behavior in male and female adolescent rats.

Amodeo LR, Greenfield VY, Humphrey DE, Varela V, Pipkin JA, Eaton SE, Johnson JD, Plant CP, Harmony ZR, Wang L, Crawford CA.

Psychopharmacology (Berl). 2015 Oct;232(19):3515-28. doi: 10.1007/s00213-015-4003-1. Epub 2015 Jul 5.

PMID:
26141193
2.

Effect of sertraline on proliferation and neurogenic differentiation of human adipose-derived stem cells.

Razavi S, Jahromi M, Amirpour N, Khosravizadeh Z.

Adv Biomed Res. 2014 Mar 25;3:97. doi: 10.4103/2277-9175.129367. eCollection 2014.

3.

Antidepressant-related adverse effects impacting treatment compliance: Results of a patient survey.

Ashton AK, Jamerson BD, L Weinstein W, Wagoner C.

Curr Ther Res Clin Exp. 2005 Mar;66(2):96-106. doi: 10.1016/j.curtheres.2005.04.006.

4.

Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.

Portman DJ, Kaunitz AM, Kazempour K, Mekonnen H, Bhaskar S, Lippman J.

Menopause. 2014 Oct;21(10):1082-90. doi: 10.1097/GME.0000000000000210.

5.

Obesity and depression in adolescence and beyond: reciprocal risks.

Marmorstein NR, Iacono WG, Legrand L.

Int J Obes (Lond). 2014 Jul;38(7):906-11. doi: 10.1038/ijo.2014.19. Epub 2014 Jan 31.

6.

A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?

Sanchez C, Reines EH, Montgomery SA.

Int Clin Psychopharmacol. 2014 Jul;29(4):185-96. doi: 10.1097/YIC.0000000000000023. Review.

7.

Diet-induced changes in the Lean Brain: Hypercaloric high-fat-high-sugar snacking decreases serotonin transporters in the human hypothalamic region.

Koopman KE, Booij J, Fliers E, Serlie MJ, la Fleur SE.

Mol Metab. 2013 Aug 7;2(4):417-22. doi: 10.1016/j.molmet.2013.07.006. eCollection 2013.

8.

The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression.

Mansoor B, Rengasamy M, Hilton R, Porta G, He J, Spirito A, Emslie GJ, Mayes TL, Clarke G, Wagner KD, Shamseddeen W, Birmaher B, Ryan N, Brent D.

J Child Adolesc Psychopharmacol. 2013 Sep;23(7):458-67. doi: 10.1089/cap.2012.0095. Epub 2013 Sep 11.

9.

Antidepressant use and diabetes mellitus risk: a meta-analysis.

Yoon JM, Cho EG, Lee HK, Park SM.

Korean J Fam Med. 2013 Jul;34(4):228-40. doi: 10.4082/kjfm.2013.34.4.228. Epub 2013 Jul 24.

10.

Relationship between SSRIs and Metabolic Syndrome Abnormalities in Patients with Generalized Anxiety Disorder: A Prospective Study.

Beyazyüz M, Albayrak Y, Eğilmez OB, Albayrak N, Beyazyüz E.

Psychiatry Investig. 2013 Jun;10(2):148-54. doi: 10.4306/pi.2013.10.2.148. Epub 2013 May 30.

11.

Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression.

Shahsavand Ananloo E, Ghaeli P, Kamkar MZ, Sadeghi M.

Daru. 2013 Jan 5;21(1):4. doi: 10.1186/2008-2231-21-4.

12.

Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.

Isaac R, Boura-Halfon S, Gurevitch D, Shainskaya A, Levkovitz Y, Zick Y.

J Biol Chem. 2013 Feb 22;288(8):5682-93. doi: 10.1074/jbc.M112.408641. Epub 2012 Dec 28.

13.

Reduced serotonin reuptake transporter (SERT) function causes insulin resistance and hepatic steatosis independent of food intake.

Chen X, Margolis KJ, Gershon MD, Schwartz GJ, Sze JY.

PLoS One. 2012;7(3):e32511. doi: 10.1371/journal.pone.0032511. Epub 2012 Mar 8.

14.

Risk factors for obesity in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.

Green DM, Cox CL, Zhu L, Krull KR, Srivastava DK, Stovall M, Nolan VG, Ness KK, Donaldson SS, Oeffinger KC, Meacham LR, Sklar CA, Armstrong GT, Robison LL.

J Clin Oncol. 2012 Jan 20;30(3):246-55. doi: 10.1200/JCO.2010.34.4267. Epub 2011 Dec 19.

15.

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

DE Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S.

World Psychiatry. 2011 Feb;10(1):52-77.

16.

Desvenlafaxine and weight change in major depressive disorder.

Tourian KA, Leurent C, Graepel J, Ninan PT.

Prim Care Companion J Clin Psychiatry. 2010;12(1):PCC.08m00746. doi: 10.4088/PCC.08m00746blu.

17.

Observational study of the impact of short-term duloxetine treatment on body weight in patients with major depressive disorder: a taiwanese perspective.

Lai CH.

Prim Care Companion J Clin Psychiatry. 2010;12(1):PCC.08100768. doi: 10.4088/PCC.08l00768blu. No abstract available.

18.

Psychotropic medication use mediates the relationship between mood and anxiety disorders and obesity: findings from a nationally representative sample.

Smits JA, Rosenfield D, Mather AA, Tart CD, Henriksen C, Sareen J.

J Psychiatr Res. 2010 Nov;44(15):1010-6. doi: 10.1016/j.jpsychires.2010.04.007.

19.

Ten putative contributors to the obesity epidemic.

McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, Benca RM, Biggio J, Boggiano MM, Eisenmann JC, Elobeid M, Fontaine KR, Gluckman P, Hanlon EC, Katzmarzyk P, Pietrobelli A, Redden DT, Ruden DM, Wang C, Waterland RA, Wright SM, Allison DB.

Crit Rev Food Sci Nutr. 2009 Nov;49(10):868-913. doi: 10.1080/10408390903372599. Review.

20.

Treating depression and anxiety in primary care.

[No authors listed]

Prim Care Companion J Clin Psychiatry. 2008;10(2):145-52. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk